Its disruption ablates ac4C modifications at specific RNA sites, and studies have shown that ac4C levels and NAT10 expression are associated with the development of various diseases, including cancers, autoimmune, cardiovascular, and inflammatory diseases [17, 18]. The gene discussed is NAT10; the disease is cancer.